Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 12 (8) , 1371-1380
- https://doi.org/10.1016/j.cgh.2013.12.011
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infectionHepatology, 2012
- A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis CJournal of Viral Hepatitis, 2012
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionGastroenterology, 2011
- Importance of Patient, Provider, and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National StudyAmerican Journal of Gastroenterology, 2011
- Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus–Infected Veterans in the United StatesAnnals of Internal Medicine, 2011
- Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral EradicationClinical Gastroenterology and Hepatology, 2010
- The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databasesAlimentary Pharmacology & Therapeutics, 2007
- Predictors of response of U.S. veterans to treatment for the hepatitis C virusHepatology, 2007
- Incidence and Predictors of Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2007
- The Effect of HIV Coinfection on the Risk of Cirrhosis and Hepatocellular Carcinoma in U.S. Veterans with Hepatitis CAmerican Journal of Gastroenterology, 2005